Form 8-K PFIZER INC For: May 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Pfizer (PFE) PT Lowered to $39 at Wolfe Research
June 1, 2020 8:36 AM EDTWolfe Research analyst Tim Anderson lowered the price target on Pfizer (NYSE: PFE) to $39.00 (from $41.00) while maintaining a Peerperform rating.
The analyst comments "We lower our peak estimate for Ibrance in 2027 (the year before patent loss) from $10.1B to $8.1B, with the decrement... More
Pfizer (PFE) PT Lowered to $36 at JPMorgan
June 1, 2020 7:41 AM EDTJPMorgan analyst Chris Schott lowered the price target on Pfizer (NYSE: PFE) to $36.00 (from $37.00) while maintaining a Neutral rating.
The analyst comments "We see a clear inflection in growth for Pfizer after the Lyrica patent expiration in 2019 with a reacceleration of the... More



